US Patent 11198679 Method of treating or preventing Ras-mediated diseases
Patent 11198679 was granted and assigned to ADT Pharmaceuticals, LLC on December, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+77 characters)
Article
Patent abstract
Disclosed are compounds, for example, a compound of formula I,
Edits on 21 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111986790
Date of Patent
December 14, 2021
0Patent Application Number
168377570
Date Filed
April 1, 2020
0Patent Citations Received
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111986790
Date of Patent
December 14, 2021
0Patent Application Number
168377570
Date Filed
April 1, 2020
0Patent Citations Received
Patent Primary Examiner
Edits on 10 Aug, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 19 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11198679 Method of treating or preventing Ras-mediated diseases
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11198679
Date of patent
December 14, 2021
Patent application number
16837757
Date Filed
April 1, 2020
Patent primary examiner
Find more entities like US Patent 11198679 Method of treating or preventing Ras-mediated diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.